您现在的位置: 首页> 研究主题> 曲马朵

曲马朵

曲马朵的相关文献在1990年到2019年内共计252篇,主要集中在药学、外科学、妇产科学 等领域,其中期刊论文235篇、会议论文2篇、专利文献18881篇;相关期刊85种,包括中华临床医师杂志(电子版)、中国药理学报:英文版、河北医科大学学报等; 相关会议2种,包括北京结直肠肛门病学术交流会暨卢克捷学术思想研讨会、2007年中华医学会麻醉学分会全国疼痛医学学术年会等;曲马朵的相关文献由678位作者贡献,包括H·库格尔曼、侯艳宁、刘会臣等。

曲马朵—发文量

期刊论文>

论文:235 占比:1.23%

会议论文>

论文:2 占比:0.01%

专利文献>

论文:18881 占比:98.76%

总计:19118篇

曲马朵—发文趋势图

曲马朵

-研究学者

  • H·库格尔曼
  • 侯艳宁
  • 刘会臣
  • J·巴托洛梅厄斯
  • 岳云
  • 杨燕燕
  • 王娜
  • 王焱林
  • 赵嘉训
  • I·兹格勒
  • 期刊论文
  • 会议论文
  • 专利文献

搜索

排序:

年份

    • 石小莉; 何琴; 肖衡; 罗盛淑
    • 摘要: 目的 对比观察术后静脉推注帕瑞昔布 、曲马朵对腹腔镜胆囊切除术后的镇痛效果.方法 将2017年3月至2018年3月该院肝胆外科收治的180例行腹腔镜胆囊切除术患者采用随机数字表法分为A组和B组,每组90例.A组患者回病房后即刻静脉推注帕瑞昔布40 mg,B组患者回病房后即刻肌内注射曲马朵2 mg/kg,两组患者12 h后均重复给药1次.两组患者术前均采用气管插管全身麻醉,手术结束前均静脉滴注昂丹司琼8 mg.记录两组患者给药后2、4、6、8、12、24 h疼痛视觉模拟评分 、发生不良反应(恶心 、呕吐 、呼吸抑制 、凝血功能异常)和追加哌替啶的情况.结果 两组患者术后2、4、6、8、12、24 h疼痛视觉模拟评分比较,差异均无统计学意义(P>0.05).A组患者恶心 、呕吐发生率[10.0%(9/90)]明显低于B组[40.0%(36/90)],差异有统计学意义(P0.05).结论 两种方法均具有较好的镇痛效果,静脉推注帕瑞昔布恶心 、呕吐发生率明显低于肌内注射曲马朵.腹腔镜胆囊切除术后患者回病房即刻 、术后12 h静脉推注帕瑞昔布镇痛具有显著的临床意义,值得推广应用.
    • Qin Ying; Li Pengtao; Xiao Zhi; Zhang Fengtao; Zhang Quan
    • 摘要: Objective To evaluate the role of P2X7 receptor in the ventrolateral periaqueductal gray (vlPAG) in tramadol-induced reduction of neuropathic pain (NP) in rats.Methods Fifty-four male clean-grade healthy Sprague-Dawley rats,aged 7 days,weighing 190-230 g,were studied.NP was induced by chronic constrictive injury (CCI) to sciatic nerve.Experiment Ⅰ Thirty-six rats were divided into 3 groups (n =12 each) using a random number table method:sham operation group (group S),group NP1 and NP plus tramadol group (group NP1 +T).Tramadol 15 mg/kg was intraperitoneally injected once a day from day 7 to day 14 after CCI in group NP1+T.The mechanical and thermal pain thresholds of the nerve-injured hindlimb were measured before CCI and on 1,5,7,10,12 and 14 days after CCI.Rats were sacrificed after measurement of pain threshold on day 14 after CCI,and the expression of P2X7 receptor in vlPAG was detected by immunohistochemistry and Western blot assay.Experiment Ⅱ Eighteen rats were divided into 3 groups (n =6 each) using a random number table method:group NP2,NP plus tramadol group (group NP2+T) and NP plus tramadol plus a specific P2X7 receptor antagonist A-438079 group (group NP2+T+A).In NP2+T+A group,a catheter was implanted in vlPAG,and the NP model was established on 5th day after successful catheterization.Tramadol 15 mg/kg was intraperitoneally injected once a day from day 7 to day 14 after CCI in group NP2+T.In group NP2+T+A,tramadol 15 mg/kg was intraperitoneally injected once a day from day 7 to day 14 after CCI,followed by a microinjection of A-438079 100 pmol (0.3 μl) via vlPAG before giving tramadol on day 14.The mechanical and thermal pain thresholds were measured at the end of the last tramadol administration and within 1 h after the end of the last tramadol administration.Results Experiment Ⅰ Compared with group S,the mechanical and thermal pain thresholds were significantly decreased at each time point after CCI,the number of P2X7 receptor positive cells was increased,and the expression of P2X7 receptor was up-regulated in the other two groups (P<0.01).Compared with group NP1,the mechanical and thermal pain thresholds were significantly increased at days 7-14 after CCI,the number of P2X7 receptor positive cells was increased,and the expression of P2X7 receptor was up-regulated in group NP1 +T (P<0.01).Experiment Ⅱ Compared with group NP2,the mechanical and thermal pain threshold were significantly increased at each time point after CCI in NP2+T and NP2 +T+A groups (P<0.01).Compared with group NP2 +T,the mechanical and thermal pain thresholds were significantly decreased at each time point after CCI in group NP2+T+A (P< 0.01).Conclusion The mechanism by which tramadol mitigates NP is partially related to enhanced function of P2X7 receptors in vlPAG of rats.%目的 评价中脑导水管周围灰质腹外侧区(vlPAG) P2X7受体在曲马多减轻大鼠神经病理性痛中的作用.方法 清洁级健康雄性SD大鼠54只,体重190~230 g,7周龄,采用慢性坐骨神经压迫性损伤(CCI)法制备大鼠神经病理性痛模型.实验Ⅰ 取大鼠36只,采用随机数字表法分成3组(n=12):假手术组(S组)、神经病理性痛组(NP1组)和神经病理性痛+曲马多组(NP1+T组).NP1+T组于CCI后第7-14天腹腔注射曲马多15 mg/kg,1次/d.于CCI前、CCI后1、5、7、10、12、14 d时测定机械痛阈与热痛阈.于CCI后14 d痛阈测定结束后处死大鼠,采用免疫组化法和Westernblot法测定vlPAG P2X7受体表达水平.实验Ⅱ 取大鼠18只,采用随机数字表法分成3组(n=6):神经病理性痛组(NP2组)、神经病理性痛+曲马多组(NP2+T组)和神经病理性痛+曲马多+P2X7受体特异性拮抗剂A-438079组(NP2+T+A组).NP2 +T+A组行vlPAG置管,置管成功后第5天建立神经病理性痛模型.NP2+T组于CCI后第7-14天腹腔注射曲马多15 mg/kg,1次/d;NP2 +T+A组于CCI后第7-14天腹腔注射曲马多15 mg/kg,1次/d,第14天曲马多给药前经vlPAG微量注射A-438079100 pmol(0.3μl).于曲马多最后一次给药结束即刻、结束后1h内每10 min测定机械痛阈与热痛阈.结果 实验Ⅰ与S组比较,其余2组各时点机械痛阈和热痛阈降低,vlPAG P2X7受体阳性细胞数增多,表达上调(P<0.01);与NP1组比较,NP1+T组CCI后7-14 d机械痛阈和热痛阈升高,vlPAGP2X7受体阳性细胞数增多,表达上调(P<0.01).实验Ⅱ 与NP2组比较,NP2 +T组和NP2+T+A组各时点热痛阈和机械痛阈升高(P<0.01);与NP2+T组比较,NP2+T+A组各时点热痛阈和机械痛阈降低(P<0.01).结论 曲马多减轻大鼠神经病理性痛的部分机制与vlPAG P2X7受体功能增强有关.
    • 王红
    • 摘要: 目的:探讨间苯三酚治疗急性腹痛的疗效.方法:收治急性腹痛患者90例,随机分为研究组和对比组,各45例.研究组采用间苯三酚治疗,对比组采用曲马多治疗.结果:研究组临床疗效明显优于对比组(P<0.05).结论:间苯三酚治疗急性腹痛,有着见效快、安全性高的特点,且阵痛的效果也比较明显.
    • 计忠伟; 刘文龙; 茹彬; 李顺; 蔡文君
    • 摘要: 目的 探讨加巴喷丁、阿米替林、曲马朵三种药物联合治疗神经病理性疼痛(neuropathic pain,NPP)的疗效及安全性.方法 选取2016年9月—2017年7月在笔者所在科治疗的NPP患者共100例,对照组47例,试验组53例.对照组单用加巴喷丁胶囊口服治疗,试验组给予加巴喷丁胶囊同时联合阿米替林片、曲马朵缓释片口服治疗,分别于用药前、用药后第1周、第4周对患者疼痛程度进行VAS评分,同时在第4周对患者出现的药物不良反应进行评估.结果 相比于治疗前,在用药第1周和第4周两组VAS评分均有下降(P<0.05),试验组VAS评分下降更为明显(P<0.05).试验组的不良反应发生率低于对照组(P<0.05).对于同一患者三种药物联合用药较单用加巴喷丁胶囊VAS评分下降(P<0.05),且不增加药物不良反应(P>0.05).结论 加巴喷丁、阿米替林、曲马朵三种药物联合能有效控制神经病理性疼痛,减轻药物不良反应.
    • 王宇飞; 梁立双
    • 摘要: 目的 比较丁丙诺啡透皮贴剂与口服曲马多缓释片对普瑞巴林治疗老年带状疱疹后神经痛患者疗效的影响.方法 将2016年1月至2017年1月就诊于山东大学齐鲁医院的182例带状疱疹后神经痛患者,采用随机数字表法随机分为丁丙诺啡+普瑞巴林组和曲马多+普瑞巴林组,每组91例,两组患者分别口服普瑞巴林联合丁丙诺啡透皮贴剂或口服普瑞巴林联合曲马多缓释片,共接受4周的药物治疗,记录两种用药方案治疗前和治疗后3、7、14、21及28 d时NRS疼痛评分及生活质量评分(简明疼痛量表BPI).记录患者恶心呕吐、头晕、嗜睡及便秘等不良反应.结果 最终有154例患者进入有效分析,每组77例.与治疗前比较,两组患者治疗后各时点NRS评分降低,差异有统计学意义(P<0.05),但两组患者NRS评分比较差异无统计学意义(P>0.05).与治疗前比较,两组患者治疗后各时点BPI评分中的各项评分均降低,差异有统计学意义(P<0.05),但组间比较差异无统计学意义(P>0.05).丁丙诺啡+普瑞巴林组恶心呕吐及便秘的发生率分别为6%和12%,明显低于曲马多+普瑞巴林组的18%和29%,差异有统计学意义(P<0.05).结论 丁丙诺啡透皮贴剂联合普瑞巴林治疗老年带状疱疹后神经痛患者,可明显缓解疼痛并改善生活质量,且其效果与口服曲马多联合普瑞巴林相当,但不良反应较少.%Objective To compare the influences of transdermal buprenorphine with oral tramadol on the treatment of postherpetic neuralgia (PHN) with pregabalin in elderly patients.Methods One hundred and fifty-four PHN patients selected from January 2016 to January 2017 in Qilu Hospital of Shandong University were randomly divided into buprenorphine + pregabalin group and tramadol + pregabalin group,77 patients in each group.Pregabalin combined with transdermal buprenorphine or oral tramadol treatment were accepted respectively in each group for 4 weeks.NRS and BPI score were assessed at baseline and 3,7,14,21 and 28 days follow-up.Adverse reactions such as nausea,vomiting,drowsiness and constipation were also recorded.Results Compared with the baseline,NRS and all components of BPI score were significantly decreased at each time point in the two groups (P<0.05),but there was no statistical difference between the two groups (P> 0.05).The rates of nausea and vomiting,constipation in the buprenorphine + pregabalin group were higher than those in the tramadol + pregabalin group respectively (6% vs.18%,12% vs.29%,P<0.05).Conclusion Buprenorphine can efficiently alleviate pain and improve the quality of life as same as tramadol,when combined with pregabalin in the treatment of PHN,but with lower adverse effects.
    • 史晓钰; 徐明哲; 潘洪飞
    • 摘要: 目的探讨曲马朵对阻生磨牙拔牙后镇痛的临床疗效。方法选取自2012年1月至2013年12月在辽宁中医药大学附属第二医院拔除阻生磨牙的60例患者为研究对象。采用随机数字表法将患者随机分为曲马朵镇痛组和索米痛镇痛组,每组各30例。比较两组患者镇痛后2、8、24、48 h的疼痛视觉模拟评分及不良反应发生情况。结果治疗2、8、24、48 h后,曲马朵镇痛组的疼痛视觉模拟评分明显低于索米痛镇痛组,两组比较,差异有统计学意义(P<0.01)。两组患者均未发生严重不良反应。结论结论曲马朵镇痛效果较索米痛可靠,且作用时间长,是拔牙术后镇痛较为理想的药物。
    • 胡春勇; 梁荣杰; 陈志健; 陈增谋
    • 摘要: 目的 比较分析醋氯芬酸与曲马多对经尿道前列腺电切术(transurethral resection ofthe prostate,TURP)后患者膀胱痉挛性疼痛的疗效与安全性.方法 选择196例于本院泌尿外科就诊的前列腺增生患者作为研究对象,随机分为两组,每组98例,A组术后给予醋氯芬酸分散片;B组术后给予曲马多缓释片.比较两组患者术后24h内VAS评分、膀胱痉挛出现的次数与持续时间及药物不良反应发生情况.结果 两组患者术后24h内各时间节点的VAS评分、膀胱痉挛出现的次数与持续时间差异无统计学意义(P>0.05).B组患者恶心、眩晕、头痛、精神不振及发热等不良反应发生率明显高于A组(P<0.05).结论 醋氯芬酸与曲马多对经TURP术后患者膀胱痉挛性疼痛的疗效相当,醋氯芬酸的安全性相对较高.%Objective To investigate the efficacy and safety of aceclofenac and tramadol on bladder spastic pain after TURP.Methods A total of 196 patients with prostatic hyperplasia in our hospital were chosen as study objects,and who were randomly divided into two groups,the patients in the group A received aceclofenac dispersible tables and the patients in the group B received tramadol sustainedrelease tablets after the TURP.The VAS pain score,frequency and duration of bladder spasm and the occurrence of adverse drug reactions were compared between the two groups in 24 hours after TURP.Results Within 24 hours after TURP,the VAS pain score of each time node,the frequency and duration of bladder spasm between the two groups had no statistical difference(P > 0.05).The incidence rate of adverse reactions such as nausea,dizziness,headache,lethargy and fever in group B was significantly higher than group A(P < 0.05).Conclusions Aceclofenac and tramadol have equivalent curative efficacy on bladder spastic pain after TURP and aceclofenac has better satety.
    • 曹凯
    • 摘要: 目的:探讨曲马朵联合依托咪酯用于全麻诱导的临床效果.方法:收治患者114例,随机分为Y组和Q组.Y组采用生理盐水+依托咪酯进行麻醉诱导,Q组采用曲马朵+依托咪酯进行麻醉诱导.结果:Q组在T1、T2、T3时刻的肌阵挛发生率明显低于Y组(P<0.05),且肌阵挛程度轻于Y组.结论:曲马朵联合依托咪酯用于全麻诱导的临床效果显著.
    • 朱东红
    • 摘要: 目的:探讨地佐辛联合曲马朵在下腹部手术术后镇痛中的应用效果.方法:收治行下腹部手术治疗患者87例,分为观察组48例和对照组39例.对照组术后镇痛采用曲马朵复合舒芬太尼,观察组采用地佐辛复合曲马朵.结果:观察组相比对照组术后VAS评分、不良反应发生率及Ramsey评分都更低(P<0.05),观察组术后60 min生命体征指标相比对照组更优(P<0.05).结论:地佐辛复合曲马朵能有效减轻下腹部手术患者术后疼痛,减轻手术引起的生命体征变化.
    • 邸宣; 邱爽; 李奎宝; 刘丽宏
    • 摘要: 目的 比较三种基本镇痛药物对腹股沟疝修补术后疼痛的镇痛效果及安全性.方法 选取首都医科大学附属北京朝阳医院2014年9月至2015年5月收治的300例无张力疝修补术术后患者,采用随机分配法将选取的患者分成三组,最终纳入273例患者,每组分别给予不同的口服镇痛药物:洛索洛芬钠组(89例),60 mg,1日3次;曲马朵组(89例),50 mg,每12h1次;洛芬待因组(95例),1片,1日3次.利用数字等级评定量表(NRS),对用药后1、2、4、8h及术后第1天、第2天和第6天进行疼痛强度评估,并记录药物不良反应的发生情况.结果 三组患者NRS评分在0h(用药前),以及用药后1、2、4、8h及术后第1天、术后第2天比较,差异有统计学意义(P<0.05);洛索洛芬钠评分最低,与其他二组比较,差异有统计学意义(P<0.05);曲马朵组与洛芬待组之间比较,差异无统计学意义(P>0.05).三组间部分不良反应发生率比较,差异有统计学意义(P<0.05),发生率从高到低依次为:曲马朵组24.72%(22例)、洛芬待因组7.37%(7例)、洛索洛芬钠组5.62%(5例).结论 洛索洛芬钠对术后急性疼痛的镇痛疗效及安全性均优于另外二组,且曲马朵不良反应较多.
  • 查看更多

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号